
Faculty, Staff and Student Publications
Publication Date
6-28-2024
Journal
Science Advances
Abstract
Declined memory is a hallmark of Alzheimer’s disease (AD). Experiments in rodents and human postmortem studies suggest that serotonin (5-hydroxytryptamine, 5-HT) plays a role in memory, but the underlying mechanisms are unknown. Here, we investigate the role of 5-HT 2C receptor (5-HT2CR) in regulating memory. Transgenic mice expressing a humanized HTR2C mutation exhibit impaired plasticity of hippocampal ventral CA1 (vCA1) neurons and reduced memory. Further, 5-HT neurons project to and synapse onto vCA1 neurons. Disruption of 5-HT synthesis in vCA1-projecting neurons or deletion of 5-HT2CRs in the vCA1 impairs neural plasticity and memory. We show that a selective 5-HT2CR agonist, lorcaserin, improves synaptic plasticity and memory in an AD mouse model. Cumulatively, we demonstrate that hippocampal 5-HT2CR signaling regulates memory, which may inform the use of 5-HT2CR agonists in the treatment of dementia.
Keywords
Animals, Humans, Receptor, Serotonin, 5-HT2C, Memory, Mice, Mice, Transgenic, Neuronal Plasticity, Alzheimer Disease, Hippocampus, Serotonin, Disease Models, Animal, CA1 Region, Hippocampal, Neurons, Serotonin 5-HT2 Receptor Agonists
DOI
10.1126/sciadv.adl2675
PMID
38941473
PMCID
PMC11212768
PubMedCentral® Posted Date
June 2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons
Comments
Associated Data
PMID: 38941473